A review of molecular mechanisms involved in toxicity of nanoparticles

Advanced Pharmaceutical Bulletin

Volumn 5, Issue 4, 2015, Pages 447-454

  Fard, Javad Khalili ^a,b,c   Jafari, Samira ^c   Eghbal, Mohammad Ali ^b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Cytotoxicity; Mechanism; Nanoparticles; Oxidative stress; Prooxidant effects; Reactivity oxygen species

Indexed keywords

CARBON NANOTUBE; GOLD NANOPARTICLE; NANOPARTICLE; QUANTUM DOT; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE;

COLORIMETRY; CYTOTOXICITY; HUMAN; IN VITRO STUDY; LDH TEST; MOLECULAR MECHANICS; MTT ASSAY; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; TOXICITY TESTING;

EID: 84949657909     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.15171/apb.2015.061     Document Type: Review

References (95)

1. Farokhzad OC, Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006;58(14):1456-9. doi: 10.1016/j.addr.2006.09.011
2. Roco MC. Nanotechnology: Convergence with modern biology and medicine. Curr Opin Biotechnol 2003;14(3):337-46. doi: 10.1016/S0958-1669(03)00068-5
3. Caruthers SD, Wickline SA, Lanza GM. Nanotechnological applications in medicine. Curr Opin Biotechnol 2007;18(1):26-30. doi: 10.1016/j.copbio.2007.01.006
4. Silva GA. Introduction to nanotechnology and its applications to medicine. Surg Neurol 2004;61(3):216-20. doi: 10.1016/j.surneu.2003.09.036
5. Singh M, Singh S, Prasad S, Gambhir IS. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Dig J Nanomater Bios 2008;3(3):115-22.
6. Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer. Annu Rev Biomed Eng 2007;9:257-88. doi: 10.1146/annurev.bioeng.9.060906.152025
7. Choi O, Hu Z. Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ Sci Technol 2008;42(12):4583-8. doi: 10.1021/es703238h
8. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in brl 3a rat liver cells. Toxicol In Vitro 2005;19(7):975-83. doi: 10.1016/j.tiv.2005.06.034
9. Zoroddu M, Medici S, Ledda A, Nurchi V, Lachowicz J, Peana M. Toxicity of nanoparticles. Current Medicinal Chem 2014;21(33):3837-53. doi: 10.2174/0929867321666140601162314
10. Marie Curie Initial Training Network - Environmental Chemoinformatics (ECO). Toxicity of nanoparticles. Project report - ITN-ECO: 2012.
11. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008;233(3):404-10. doi: 10.1016/j.taap.2008.09.015
12. Sharma V, Shukla RK, Saxena N, Parmar D, Das M, Dhawan A. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol Lett 2009;185(3):211-8. doi: 10.1016/j.toxlet.2009.01.008
13. Wang F, Yu L, Monopoli MP, Sandin P, Mahon E, Salvati A, et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine 2013;9(8):1159-68. doi: 10.1016/j.nano.2013.04.010
14. Elsaesser A, Howard CV. Toxicology of nanoparticles. Adv Drug Deliv Rev 2012;64(2):129-37. doi: 10.1016/j.addr.2011.09.001
15. Regoli F, Giuliani ME. Oxidative pathways of chemical toxicity and oxidative stress biomarkers in marine organisms. Mar Environ Res 2014;93:106-17. doi: 10.1016/j.marenvres.2013.07.006
16. Jomova K, Baros S, Valko M. Redox active metal-induced oxidative stress in biological systems. Transition Met Chem 2012;37(2):127-34. doi: 10.1007/s11243-012-9583-6
17. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, et al. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 2011;14(8):1505-17. doi: 10.1089/ars.2010.3576
18. Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ, De Smedt SC, Braeckmans K. Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 2011;6(5):446-65. doi: 10.1016/j.nantod.2011.08.001
19. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev 2012;112(4):2323-38. doi: 10.1021/cr2002596
20. Fischer J, Prosenc MH, Wolff M, Hort N, Willumeit R, Feyerabend F. Interference of magnesium corrosion with tetrazolium-based cytotoxicity assays. Acta Biomater 2010;6(5):1813-23. doi: 10.1016/j.actbio.2009.10.020
21. Rabolli V, Thomassen LC, Princen C, Napierska D, Gonzalez L, Kirsch-Volders M, et al. Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types. Nanotoxicology 2010;4(3):307-18. doi: 10.3109/17435390.2010.482749
22. Kumbiçak Ü, Çavas T, Çinkiliç N, Kumbiçak Z, Vatan Ö, Yilmaz D. Evaluation of in vitro cytotoxicity and genotoxicity of copper-zinc alloy nanoparticles in human lung epithelial cells. Food Chem Toxicol 2014;73:105-12. doi: 10.1016/j.fct.2014.07.040
23. Fotakis G, Timbrell JA. In vitro cytotoxicity assays: Comparison of ldh, neutral red, mtt and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006;160(2):171-7. doi: 10.1016/j.toxlet.2005.07.001
24. Crouch SPM, Kozlowski R, Slater KJ, Fletcher J. The use of atp bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 1993;160(1):81-8. doi: 10.1016/0022-1759(93)90011-U
25. Schiewe MH, Hawk EG, Actor DI, Krahn MM. Use of a bacterial bioluminescence assay to assess toxicity of contaminated marine sediments. Can J Fish Aquat Sci 1985;42(7):1244-8. doi: 10.1139/f85-154
26. Benton MJ, Malott ML, Knight SS, Cooper CM, Benson WH. Influence of sediment composition on apparent toxicity in a solid-phase test using bioluminescent bacteria. Environ Toxicol Chem 1995;14(3):411-4. doi: 10.1002/etc.5620140309
27. Asare N, Instanes C, Sandberg WJ, Refsnes M, Schwarze P, Kruszewski M, et al. Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology 2012;291(1-3):65-72. doi: 10.1016/j.tox.2011.10.022
28. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983;64(3):313-20. doi: 10.1016/0022-1759(83)90438-6
29. van Meerloo J, Kaspers GJ, Cloos J. Cell sensitivity assays: The MTT assay. In: Cree IA, editor. Cancer cell culture. Hatfield: Springer; 2011. P. 237-45.
30. Malich G, Markovic B, Winder C. The sensitivity and specificity of the mts tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 1997;124(3):179-92. doi: 10.1016/S0300-483X(97)00151-0
31. Cho WS, Duffin R, Thielbeer F, Bradley M, Megson IL, MacNee W, et al. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol Sci 2012;126(2):469-77. doi: 10.1016/10.1093/toxsci/kfs006
32. Donaldson K, Poland CA, Schins RP. Possible genotoxic mechanisms of nanoparticles: Criteria for improved test strategies. Nanotoxicology 2010;4(4):414-20. doi: 10.3109/17435390.2010.482751
33. Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol 2012;9(1):20. doi: 10.1186/1743-8977-9-20
34. Li Y, Zhang W, Niu J, Chen Y. Surface-coating-dependent dissolution, aggregation, and reactive oxygen species (ros) generation of silver nanoparticles under different irradiation conditions. Environ Sci Technol 2013;47(18):10293-301. doi: 10.1021/es400945v
35. Nishanth RP, Jyotsna RG, Schlager JJ, Hussain SM, Reddanna P. Inflammatory responses of raw 264.7 macrophages upon exposure to nanoparticles: Role of ros-nfκb signaling pathway. Nanotoxicology 2011;5(4):502-16. doi: 10.3109/17435390.2010.541604
36. Luna-Velasco A, Field JA, Cobo-Curiel A, Sierra-Alvarez R. Inorganic nanoparticles enhance the production of reactive oxygen species (ros) during the autoxidation of L-3,4-dihydroxyphenylalanine (L-dopa). Chemosphere 2011;85(1):19-25. doi: 10.1016/j.chemosphere.2011.06.053
37. Shao W, Arghya P, Yiyong M, Rodes L, Prakash S. Carbon nanotubes for use in medicine: Potentials and limitations. In: Suzuki S, editor. Syntheses and Applications of Carbon Nanotubes and Their Composites. Croatia: InTech; 2013. P. 285-311.
38. De Volder MF, Tawfick SH, Baughman RH, Hart AJ. Carbon nanotubes: Present and future commercial applications. Science 2013;339(6119):535-9. doi: 10.1126/science.1222453
39. O'connell MJ. Carbon nanotubes: Properties and applications. Boca Raton: CRC Press; 2012.
40. Shvedova AA, Pietroiusti A, Fadeel B, Kagan VE. Mechanisms of carbon nanotube-induced toxicity: Focus on oxidative stress. Toxicol Appl Pharmacol 2012;261(2):121-33. doi: 10.1016/j.taap.2012.03.023
41. Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, et al. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics. Nanotoxicology 2010;4(2):207-46. doi: 10.3109/17435390903569639
42. Campagnolo L, Massimiani M, Palmieri G, Bernardini R, Sacchetti C, Bergamaschi A, et al. Biodistribution and toxicity of pegylated single wall carbon nanotubes in pregnant mice. Part Fibre Toxicol 2013;10(1):21. doi: 10.1186/1743-8977-10-21
43. Clift MJ, Endes C, Vanhecke D, Wick P, Gehr P, Schins RP, et al. A comparative study of different in vitro lung cell culture systems to assess the most beneficial tool for screening the potential adverse effects of carbon nanotubes. Toxicol Sci 2014;137(1):55-64. doi: 10.1093/toxsci/kft216
44. Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 2011;178(6):2587-600. doi: 10.1016/j.ajpath.2011.02.040
45. Yin ZF, Wu L, Yang HG, Su YH. Recent progress in biomedical applications of titanium dioxide. Phys Chem Chem Phys 2013;15(14):4844-58. doi: 10.1039/C3CP43938K
46. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 2012;46(4):2242-50. doi: 10.1021/es204168d
47. Sha B, Gao W, Han Y, Wang S, Wu J, Xu F, et al. Potential application of titanium dioxide nanoparticles in the prevention of osteosarcoma and chondrosarcoma recurrence. J Nanosci Nanotechnol 2013;13(2):1208-11. doi: 10.1166/jnn.2013.6081
48. 2 nanoparticle-induced disruption of calcium homeostasis in human lens epithelial cells. Photochem Photobiol 2014;90(6):1324-31. doi: 10.1111/php.12322
49. 2-based nanofilaments: ESR and AFM assays. Nanotoxicology 2012;6(8):813-24. doi: 10.3109/17435390.2011.625129
50. 2 nanoparticles in human hepatoma hepg2 cells. Nanotoxicology 2011;5(3):341-53. doi: 10.3109/17435390.2010.507316
51. 2 rutile/anatase mixed phase nanoparticles on Caco-2 cells. Chem Res Toxicol 2012;25(3):646-55. doi: 10.1021/tx200334k
52. 2 nanoparticles induce dysfunction and activation of human endothelial cells. Chem Res Toxicol 2012;25(4):920-30. doi: 10.1021/tx200551u
53. 2 nanoparticles in anatase and rutile crystal phase. Biol Trace Elem Res 2011;141(1-3):3-15. doi: 10.1007/s12011-010-8707-0
54. 2 nanoparticles influences their phototoxicity: An in vitro investigation. Arch Toxicol 2013;87(1):99-109. doi: 10.1007/s00204-012-0912-5
55. 2, silver and fullerene nanoparticles using a set of recombinant luminescent escherichia coli strains: Differentiating the impact of particles and solubilised metals. Anal Bioanal Chem 2010;398(2):701-16. doi: 10.1007/s00216-010-3962-7
56. 2 nanoparticles induces histamine secretion in mast cells. Part Fibre Toxicol 2012;9:2. doi: 10.1186/1743-8977-9-2
57. Scherbart AM, Langer J, Bushmelev A, van Berlo D, Haberzettl P, van Schooten FJ, et al. Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms. Part Fibre Toxicol 2011;8:31. doi: 10.1186/1743-8977-8-31
58. Fu J, Rong G, Deng Y. Mammalian cell cytotoxicity and genotoxicity of metallic nanoparticles. Adv Sci Lett 2012;5(1):294-8. doi: 10.1166/asl.2012.1946
59. 2) nanoparticles on human erythrocyte and lymphocyte cells in vitro. J Appl Toxicol 2013;33(10):1097-110. doi: 10.1002/jat.2863
60. 2) nanoparticles. Arch Toxicol 2013;87(6):1075-86. doi: 10.1007/s00204-012-0938-8
61. Osinski M, Parak WJ, Jovin TM, Yamamoto K. Colloidal Quantum Dots for Biomedical Applications V, SPIE International Symposium on Biomedical Optics BiOS 2010, Vol. 7575, Paper 75750Z San Francisco, California, 23-25 January 2010.
62. Chen N, He Y, Su Y, Li X, Huang Q, Wang H, et al. The cytotoxicity of cadmium-based quantum dots. Biomaterials 2012;33(5):1238-44. doi: 10.1016/j.biomaterials.2011.10.070
63. Hoshino A, Hanada S, Yamamoto K. Toxicity of nanocrystal quantum dots: The relevance of surface modifications. Arch Toxicol 2011;85(7):707-20. doi: 10.1007/s00204-011-0695-0
64. Zheng X, Tian J, Weng L, Wu L, Jin Q, Zhao J, et al. Cytotoxicity of cadmium-containing quantum dots based on a study using a microfluidic chip. Nanotechnology 2012;23(5):055102. doi: 10.1088/0957-4484/23/5/055102
65. Singh BR, Singh BN, Khan W, Singh HB, Naqvi AH. ROS-mediated apoptotic cell death in prostate cancer LNCaP cells induced by biosurfactant stabilized CdS quantum dots. Biomaterials 2012;33(23):5753-67. doi: 10.1016/j.biomaterials.2012.04.045
66. Kauffer FA, Merlin C, Balan L, Schneider R. Incidence of the core composition on the stability, the ROS production and the toxicity of CdSe quantum dots. J Hazard Mater 2014;268:246-55. doi: 10.1016/j.jhazmat.2014.01.029
67. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chem Soc Rev 2012;41(6):2256-82. doi: 10.1039/C1CS15166E
68. Tiwari PM, Vig K, Dennis VA, Singh SR. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011;1(1):31-63. doi: 10.3390/nano1010031
69. Yeh YC, Creran B, Rotello VM. Gold nanoparticles: Preparation, properties, and applications in bionanotechnology. Nanoscale 2012;4(6):1871-80. doi: 10.1039/C1NR11188D
70. Lim ZZJ, Li JEJ, Ng CT, Yung LYL, Bay BH. Gold nanoparticles in cancer therapy. Acta Pharmacol Sin 2011;32(8):983-90. doi: 10.1038/aps.2011.82
71. Jain S, Hirst DG, O'sullivan JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 2012;85(1010):101-13. doi: 10.1259/bjr/59448833
72. Heo DN, Yang DH, Moon HJ, Lee JB, Bae MS, Lee SC, et al. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 2012;33(3):856-66. doi: 10.1016/j.biomaterials.2011.09.064
73. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: A review of in vitro and in vivo studies. Chem Soc Rev 2011;40(3):1647-71. doi: 10.1039/C0CS00018C
74. Taylor U, Barchanski A, Garrels W, Klein S, Kues W, Barcikowski S, et al. Toxicity of gold nanoparticles on somatic and reproductive cells. In: Zahavy E, Ordentlich A, Yitzhaki S, Shafferman A, editors. Nano-biotechnology for biomedical and diagnostic research. New York: Springer; 2012. P. 125-33.
75. Loumaigne M, Richard A, Laverdant J, Nutarelli D, Débarre A. Ligand-induced anisotropy of the two-photon luminescence of spherical gold particles in solution unraveled at the single particle level. Nano lett 2010;10(8):2817-24. doi: 10.1021/nl100737y
76. Arnida, Janát-Amsbury MM, Ray A, Peterson CM, Ghandehari H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 2011;77(3):417-23. doi: 10.1016/j.ejpb.2010.11.010
77. Pissuwan D, Niidome T, Cortie MB. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release 2011;149(1):65-71. doi: 10.1016/j.jconrel.2009.12.006
78. Coradeghini R, Gioria S, García CP, Nativo P, Franchini F, Gilliland D, et al. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol lett 2013;217(3):205-16. doi: 10.1016/j.toxlet.2012.11.022
79. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 2010;28(11):580-8. doi: 10.1016/j.tibtech.2010.07.006
80. García-Barrasa J, López-de-Luzuriaga JM, Monge M. Silver nanoparticles: Synthesis through chemical methods in solution and biomedical applications. Cent Eur J Chem 2011;9(1):7-19. doi: 10.2478/s11532-010-0124-x
81. Wang Y, Newell BB, Irudayaraj J. Folic acid protected silver nanocarriers for targeted drug delivery. J Biomed Nanotechnol 2012;8(5):751-9. doi: 10.1166/jbn.2012.1437
82. Zhou W, Ma Y, Yang H, Ding Y, Luo X. A label-free biosensor based on silver nanoparticles array for clinical detection of serum p53 in head and neck squamous cell carcinoma. Int J Nanomedicine 2011;6(1):381-6. doi: 10.2147/IJN.S13249
83. Wang J, Song D, Wang L, Zhang H, Zhang H, Sun Y. Design and performances of immunoassay based on spr biosensor with au/ag alloy nanocomposites. Sensors Actuators B: Chem 2011;157(2):547-53. doi: 10.1016/j.snb.2011.05.020
84. Mei N, Zhang Y, Chen Y, Guo X, Ding W, Ali SF, et al. Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ Mol Mutagen 2012;53(6):409-19. doi: 10.1002/em.21698
85. Kim S, Ryu DY. Silver nanoparticle-induced oxidative stress, genotoxicity and apoptosis in cultured cells and animal tissues. J Appl Toxicol 2013;33(2):78-89. doi: 10.1002/jat.2792
86. Xin L, Wang J, Wu Y, Guo S, Tong J. Increased oxidative stress and activated heat shock proteins in human cell lines by silver nanoparticles. Hum Exp Toxicol 2015;34(3):315-23. doi: 10.1177/0960327114538988
87. Yang X, Gondikas AP, Marinakos SM, Auffan M, Liu J, Hsu-Kim H, et al. Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in caenorhabditis elegans. Environ Sci Technol 2012;46(2):1119-27. doi: 10.1021/es202417t
88. Batchelor-McAuley C, Tschulik K, Neumann C, Laborda E, Compton RG. Why are silver nanoparticles more toxic than bulk silver? Towards understanding the dissolution and toxicity of silver nanoparticles. Int J Electrochem Sci 2014;9(3):1132-8.
89. Gliga AR, Skoglund S, Wallinder IO, Fadeel B, Karlsson HL. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: The role of cellular uptake, agglomeration and ag release. Part Fibre Toxicol 2014;11(1):11. doi: 10.1186/1743-8977-11-11
90. Sanwlani S, Rawat K, Pal M, Bohidar HB, Verma AK. Cellular uptake induced biotoxicity of surface-modified cdse quantum dots. J Nanopart Res 2014;16:2382. doi: 10.1007/s11051-014-2382-6
91. 2) to developing zebrafish embryos. J Nanopart Res 2014;16:2550. doi: 10.1007/s11051-014-2550-8
92. Pujalté I, Passagne I, Brouillaud B, Tréguer M, Durand E, Ohayon-Courtès C, et al. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part Fibre Toxicol 2011;8:10. doi: 10.1186/1743-8977-8-10
93. Lee YH, Cheng FY, Chiu HW, Tsai JC, Fang CY, Chen CW, et al. Cytotoxicity, oxidative stress, apoptosis and the autophagic effects of silver nanoparticles in mouse embryonic fibroblasts. Biomaterials 2014;35(16):4706-15. doi: 10.1016/j.biomaterials.2014.02.021
94. Chueh PJ, Liang RY, Lee YH, Zeng ZM, Chuang SM. Differential cytotoxic effects of gold nanoparticles in different mammalian cell lines. J Hazard Mater 2014;264:303-12. doi: 10.1016/j.jhazmat.2013.11.031
95. Grabowski N, Hillaireau H, Vergnaud J, Santiago LA, Kerdine-Romer S, Pallardy M, et al. Toxicity of surface-modified plga nanoparticles toward lung alveolar epithelial cells. Int J Pharm 2013;454(2):686-94. doi: 10.1016/j.ijpharm.2013.05.025